AtoMOXetine: May enhance the tachycardic effect of Beta2-Agonists. Monitor therapy AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics. Monitor therapy Atosiban: Beta2-Agonists may enhance the adverse / toxic effect of Atosiban...
Lowering Agents may enhance the hypotensive effect of Antipsychotic Agents (Second Generation [Atypical]). Monitor therapy Atosiban: Calcium Channel Blockers may enhance the adverse/toxic effect of Atosiban. Specifically, there may be an increased risk for pulmonary edema and/or dyspnea. Monitor therapy...
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Xolair injection (omalizumab) is used to help improve allergic asthma, nasal polyps, and chronic ...
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Nucala is used to treat severe eosinophilic asthma, eosinophilic COPD, chronic rhinosinusitis with ...
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
